Dataset from A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

This trial is conducted globally. The aim of this trial is to compare efficacy and safety of insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy in combination with metformin in subjects with type 2 diabetes mellitus.

本试验在全球范围内开展。本试验旨在对比德谷胰岛素利拉鲁肽（insulin degludec/liraglutide，IDegLira）联合二甲双胍与基础-餐时胰岛素治疗联合二甲双胍，在2型糖尿病受试者中的疗效与安全性。